Screening rectal culture to identify fluoroquinolone-resistant organisms before transrectal prostate biopsy: Do the culture results between office visit and biopsy correlate?

Urology

Volumn 82, Issue 1, 2013, Pages 67-73

  Liss, Michael A ^a,b   Nakamura, Kristen K ^c   Meuleners, Rachel ^b   Kolla, Surendra B ^b   Dash, Atreya ^a,b   Peterson, Ellena M ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PSEUDOMONAS; SENSITIVITY AND SPECIFICITY;

EID: 84879518985     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.02.068     Document Type: Article

References (24)

1. S. Loeb, H.B. Carter, and S.I. Berndt Complications after prostate biopsy: data from SEER-Medicare J Urol 186 2011 1830 1834
2. J.S. Wolf Jr., C.J. Bennett, and R.R. Dmochowski Best practice policy statement on urologic surgery antimicrobial prophylaxis J Urol 179 2008 1379 1390
3. M. Aron, T.P. Rajeev, and N.P. Gupta Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study BJU Int 85 2000 682 685
4. R.K. Nam, R. Saskin, and Y. Lee Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy J Urol 183 2010 963 968
5. O.M. Zaytoun, E.H. Vargo, and R. Rajan Emergence of fluoroquinolone- resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment Urology 77 2011 1035 1041
6. S. Loeb, S. van den Heuvel, and X. Zhu Infectious complications and hospital admissions after prostate biopsy in a European randomized trial Eur Urol 61 2012 1110 1114
7. J. Feliciano, E. Teper, and M. Ferrandino The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? J Urol 179 2008 952 955 discussion: 5
8. D. Batura, G.G. Rao, and P.B. Nielsen Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy BJU Int 106 2010 1017 1020
9. M.A. Liss, A. Chang, and R. Santos Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy J Urol 185 2011 1283 1288
10. D. Steensels, K. Slabbaert, and L. De Wever Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy-should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect 18 2012 575 581
11. C.A. Duplessis, M. Bavaro, and M.P. Simons Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates Urology 79 2012 556 563
12. A.K. Taylor, T.R. Zembower, and R.B. Nadler Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care J Urol 187 2012 1275 1279
13. Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement M100-S20 2010 Clinical and Laboratory Standards Institute, NCCLS Wayne, PA
14. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
15. J. Sim, and C.C. Wright The kappa statistic in reliability studies: use, interpretation, and sample size requirements Phys Ther 85 2005 257 268
16. N.A. Obuchowski ROC analysis AJR Am J Roentgenol 184 2005 364 372
17. J.P. Horcajada, J. Vila, and A. Moreno-Martinez Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis J Antimicrob Chemother 49 2002 55 59
18. M.J. Claesson, S. Cusack, and O. O'Sullivan Composition, variability, and temporal stability of the intestinal microbiota of the elderly Proc Natl Acad Sci U S A 108 suppl 1 2011 4586 4591
19. J.N. Maslow, B. Lee, and E. Lautenbach Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility Emerg Infect Dis 11 2005 889 894
20. T. Madden, A. Doble, S.H. Aliyu, and D.E. Neal Infective complications after transrectal ultrasound-guided prostate biopsy following a new protocol for antibiotic prophylaxis aimed at reducing hospital-acquired infections BJU Int 108 2011 1597 1602
21. F.M. Wagenlehner, E. van Oostrum, and P. Tenke Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study Eur Urol 63 2013 521 527
22. M.A. Liss, K.K. Nakamura, and E.M. Peterson Comparison of broth enhancement to direct plating for screening of rectal cultures for ciprofloxacin-resistant Escherichia coli J Clin Microbiol 51 2013 249 252
23. R. Davis, A. Markham, and J.A. Balfour Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability Drugs 51 1996 1019 1074
24. T. Bergan Extravascular penetration of ciprofloxacin. A review Diagn Microbiol Infect Dis 13 1990 103 114